Intraoperative radiotherapy for early breast cancer — insufficient evidence to change practice

We argue that the evidence remains insufficient for use of intraoperative radiotherapy (IORT) in women with early stage breast cancer outside of a clinical trial, as the recently reported TARGIT-A trial does not provide sufficient evidence to conclude that IORT is superior to no radiotherapy.

Detalles Bibliográficos
Autores principales: Sasieni, Peter D., Sawyer, Elinor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
News & Views
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576112/
https://www.ncbi.nlm.nih.gov/pubmed/33087894
http://dx.doi.org/10.1038/s41571-020-00444-2
Descripción
Sumario:We argue that the evidence remains insufficient for use of intraoperative radiotherapy (IORT) in women with early stage breast cancer outside of a clinical trial, as the recently reported TARGIT-A trial does not provide sufficient evidence to conclude that IORT is superior to no radiotherapy.

Ejemplares similares